Compare DraftKings Inc (DKNG) vs UnitedHealth Group Inc (UNH) Price & Performance

DraftKings (DKNG) trades at $19.87, down 3.76% recently and near a 52-week low of $18.95, reflecting bearish technical signals. The company achieved profitability in 2025 with $6.05 billion revenue and $3.71 million net income, but recent quarterly EPS misses and a negative net income margin of -2.68% for 2026 indicate challenges. Valuation ratios remain elevated, with a P/E of 246.33, while cash flow trends show volatility, with 2025 net cash flow positive at $274.40 million but projected negative for 2026.

The outlook is mixed: strong analyst consensus with a $33.13 price target and 75% buy ratings suggests long-term growth potential from sportsbook expansion and prediction markets, but high valuation, earnings volatility, and competitive pressures pose significant risks. Investors should weigh the company's growth initiatives against execution risks and market sentiment shifts.

UnitedHealth Group (UNH) trades at $370.95, down 1.34% on the day, amid a bearish technical signal from moving averages. The company reported strong Q2 2026 earnings, beating estimates with EPS of $6.38 versus $4.91 expected, and raised full-year guidance. Revenue for 2025 reached $447.57 billion, though net income margin declined to 2.69%. Analyst consensus remains strongly bullish with an 82.69% buy rating and a $470.11 price target, suggesting significant upside from current levels.

UNH presents a compelling investment case driven by earnings beats, raised 2026 outlook, and strategic initiatives like AI investment in Optum. Key risks include regulatory pressures in healthcare, volatility from Medicare Advantage plan changes, and margin compression. The stock's valuation at a P/E of 23.84 appears reasonable given growth prospects, but investors should weigh execution risks against the positive analyst sentiment and institutional backing.